Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Stepped up their Corporate Presentation Game

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Oct 30, 2020 12:43pm

81 Views

Post# 31813589

RE:RE:Stepped up their Corporate Presentation Game

It really does feel like this presentation tells the story the way that we've come to understand it. And it just flows so well, this is what the company is asking people to invest in laid out in a clear, understandable way.

SPCEO1 wrote: Wino - you should be trying to figure out where/how you collect your consulting check from TH!

That is a first class corporate presentation - what we have been lookng for has finally arrived.

SPCEO1 wrote: Check out the new corporate presenatation - big improvement!

https://www.theratech.com/investisseurs/presentations-et-evenements/ew corporate presentation - big improvement!